로딩 중…
StockDiggingStockDigging

Zimmer Biomet Holdings, Inc.

ZBH· NYSE
$97.33+2.97%
2026-11-02

Financials

Valuation Metrics

Zimmer Biomet Holdings, Inc.'s Market Cap is $18.83B. At end of 2025 it was $17.73B. Ranked #619 of 3,118 in US market (top 20%), #429 of 1,644 on NYSE (top 26%), #43 of 203 in Health Care Equipment & Services (top 21%) by Market Cap.

Investment Metrics(as of 2026-11-02)

MetricValue
Size
Market Cap$18.83B
Revenue$8.51B
Net Income$807M
Total Assets$22.80B
Net Assets$12.62B
Employees17,000
Value
P/E23.34x
P/B1.49x
P/S2.21x
EV/EBITDA13.22x
FCF Yield9.72%
Profitability
ROE6.39%
ROA3.54%
Op. Margin15.73%
Revenue Growth8.62%
Earnings Growth-2.02%
Financial Health
Debt Ratio80.52%
Total Debt$7.48B
FCF$1.83B
Cash$410M
Current Ratio1.69x
Net Debt/EBITDA3.61x
Dividend
Div. Yield1.00%
Div. Growth-0.40%
Performance
1Y Return-2.95%
1M Return10.24%
From 52W High-5.89%
1Y MDD-22.67%
Trading
Volume1,876,815 shares
Trading Value$181M
Per Share
EPS$4.17
BPS$65.25

Company Info

CEO Mr. Ivan Tornos
Employees 17,000
HQ Warsaw, United States

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.